|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-10-8
|
|
pubmed:abstractText |
There are conflicting data concerning the effect of treatment with glucose-insulin-potassium (GIK) in ST segment elevation myocardial infarction (STEMI). Early studies showed beneficial effects of GIK, however, recent large sample size trials did not confirm this, or suggested only benefits in patients without heart failure. We aimed to evaluate long-term effects of GIK in patients with STEMI without signs of heart failure, all treated with reperfusion therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1874-1754
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
31
|
|
pubmed:volume |
122
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
52-5
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17223212-Aged,
pubmed-meshheading:17223212-Angioplasty, Balloon, Coronary,
pubmed-meshheading:17223212-Female,
pubmed-meshheading:17223212-Follow-Up Studies,
pubmed-meshheading:17223212-Glucose,
pubmed-meshheading:17223212-Humans,
pubmed-meshheading:17223212-Insulin,
pubmed-meshheading:17223212-Male,
pubmed-meshheading:17223212-Middle Aged,
pubmed-meshheading:17223212-Myocardial Infarction,
pubmed-meshheading:17223212-Potassium,
pubmed-meshheading:17223212-Recurrence,
pubmed-meshheading:17223212-Thrombolytic Therapy,
pubmed-meshheading:17223212-Time Factors,
pubmed-meshheading:17223212-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II.
|
|
pubmed:affiliation |
Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
